Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRY-box transcription factor 6 (SOX6) is a highly conserved DNA-binding protein that belongs to the SOXD subfamily of the SOX transcription factor family. It is characterized by a high mobility group (HMG) DNA-binding domain and drives key processes in cartilage formation, neurogenesis, erythrocyte development, and muscle maintenance by modulating transcription of lineage-specific genes. SOX6 often cooperates with related SOX proteins (notably SOX5 and SOX9) and other protein cofactors, exerting both activating and repressive effects on gene expression depending on cellular context. Dysregulation of SOX6 is implicated in skeletal abnormalities, neurodevelopmental conditions, and some cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRY-box transcription factor 6 (SOX6).